AGN 2.47% 79.0¢ argenica therapeutics limited

Ann: First Patient Dosed in Phase 2 Stroke Trial of ARG-007, page-21

  1. 168 Posts.
    lightbulb Created with Sketch. 90
    that's good guys if they have plenty of cash , I don't want to buy more if there is imminent capital raise is required. I have pretty good runs with NEU , DXB and MSB and RHT, i personally think ARG has a huge potential even much more than MSB if they get it right.
 
watchlist Created with Sketch. Add AGN (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.